News

Assistant professor of biochemistry and molecular biology at Saint Louis University Mee-Ngan F. Yap, Ph.D studied staph that had been treated with the antibiotic azithromycin. During the study

If approved in the EU, ruxolitinib could provide the first targeted treatment option for these patients. PV is a chronic, incurable blood cancer associated with an overproduction of

Lupuzor (also called as Rigerimod, IPP-201101 and P140) received fast track designation from the US Food and Drug Administration (FDA) as well as approval to start Phase III

Hypoparathyroidism is a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, or PTH. Natpara, a bioengineered replica of human PTH, is expected to be available in

The Fast Track designation process of the FDA is designed to facilitate the development and expedite the review and approval of drugs intended to treat serious or life

"Retinal vein occlusion is a common retinal vascular disorder with an estimated 16.4 million people affected worldwide, and it is a severe disease which is potentially blinding if

The in-clinic, randomized, placebo-controlled, double-blind Phase IIa trial will evaluate patients with epilepsy using the intermittent photo-stimulation model. The trial’s primary aim is to evaluate the safety and

Bexsero is the only meningitis B vaccine approved in the US with a two-dose regimen and a flexible dosing schedule[1]. As part of the accelerated approval process, Novartis

The OS results in 123 patients demonstrated that aldoxorubicin-treated patients demonstrated a 27 percent reduction in the risk of death compared to patients treated with doxorubicin (HR 0.73: